$CPAY
CORPAY, INC.

2023 Q3 Form 10-Q Financial Statement

#000162828023028574 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $970.9M $948.2M $861.3M
YoY Change 8.72% 10.09% 29.05%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $233.8M $245.8M $412.4M
YoY Change -45.2% -40.4% 131.36%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $84.70M $83.68M $78.47M
YoY Change 9.7% 6.63% 13.32%
% of Gross Profit
Operating Expenses $233.8M $245.8M $490.8M
YoY Change -53.6% -49.92% 175.37%
Operating Profit $445.0M $412.7M $370.5M
YoY Change 14.34% 11.38% 24.48%
Interest Expense -$94.70M -$87.60M -$14.76M
YoY Change 107.75% 493.4% -125.94%
% of Operating Profit -21.28% -21.23% -3.98%
Other Income/Expense, Net -$74.88M -$86.08M -$12.06M
YoY Change 1930.45% 613.53% -65.62%
Pretax Income $370.1M $326.6M $343.7M
YoY Change 8.88% -4.97% 30.91%
Income Tax $98.60M $86.87M $81.48M
% Of Pretax Income 26.64% 26.6% 23.71%
Net Earnings $271.5M $239.7M $262.2M
YoY Change 9.08% -8.57% 33.59%
Net Earnings / Revenue 27.96% 25.28% 30.44%
Basic Earnings Per Share $3.71 $3.24 $3.42
Diluted Earnings Per Share $3.64 $3.20 $3.351M
COMMON SHARES
Basic Shares Outstanding 73.96M shares 73.83M shares 77.34M shares
Diluted Shares Outstanding 74.60M shares 75.00M shares 78.24M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.094B $1.254B $1.423B
YoY Change -16.97% -11.86% 9.36%
Cash & Equivalents $1.094B $1.254B $1.423B
Short-Term Investments
Other Short-Term Assets $1.714B $1.961B $1.352B
YoY Change 7.0% 45.04% 15.96%
Inventory
Prepaid Expenses
Receivables $2.655B $2.461B $2.449B
Other Receivables $1.396B $1.248B $1.600B
Total Short-Term Assets $6.860B $6.924B $6.823B
YoY Change 4.16% 1.47% 29.87%
LONG-TERM ASSETS
Property, Plant & Equipment $330.0M $329.1M $260.6M
YoY Change 21.06% 26.31% 20.26%
Goodwill $5.554B $5.474B
YoY Change 9.56%
Intangibles $2.165B $2.107B
YoY Change -0.2%
Long-Term Investments $68.00M $69.72M $67.07M
YoY Change -8.54% 3.96% 465.63%
Other Assets $287.7M $275.5M $262.5M
YoY Change -8.62% 4.97% 19.06%
Total Long-Term Assets $8.404B $8.255B $7.887B
YoY Change 6.38% 4.67% 1.47%
TOTAL ASSETS
Total Short-Term Assets $6.860B $6.924B $6.823B
Total Long-Term Assets $8.404B $8.255B $7.887B
Total Assets $15.26B $15.18B $14.71B
YoY Change 5.37% 3.18% 12.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.895B $1.680B $2.015B
YoY Change 11.88% -16.64% 27.67%
Accrued Expenses $393.4M $392.7M $348.3M
YoY Change 0.89% 12.73% 20.05%
Deferred Revenue $2.264B $2.286B
YoY Change
Short-Term Debt $0.00 $0.00 $1.600B
YoY Change -100.0% -100.0% 60.0%
Long-Term Debt Due $2.346B $2.071B $508.1M
YoY Change 135.98% 307.64% -62.25%
Total Short-Term Liabilities $6.738B $6.436B $6.432B
YoY Change 1.51% 0.06% 29.14%
LONG-TERM LIABILITIES
Long-Term Debt $4.637B $4.678B $4.768B
YoY Change -2.28% -1.87% 27.72%
Other Long-Term Liabilities $280.6M $262.2M $256.7M
YoY Change -7.76% 2.17% -0.92%
Total Long-Term Liabilities $5.467B $5.479B $5.024B
YoY Change 8.27% 9.06% 10.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.738B $6.436B $6.432B
Total Long-Term Liabilities $5.467B $5.479B $5.024B
Total Liabilities $12.21B $11.92B $12.02B
YoY Change -0.44% -0.89% 26.05%
SHAREHOLDERS EQUITY
Retained Earnings $7.937B $7.665B
YoY Change 13.62%
Common Stock $3.228B $3.177B
YoY Change 7.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.059B $3.263B $2.688B
YoY Change
Total Liabilities & Shareholders Equity $15.26B $15.18B $14.71B
YoY Change 5.37% 3.18% 12.92%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $271.5M $239.7M $262.2M
YoY Change 9.08% -8.57% 33.59%
Depreciation, Depletion And Amortization $84.70M $83.68M $78.47M
YoY Change 9.7% 6.63% 13.32%
Cash From Operating Activities $77.20M $499.0M $154.1M
YoY Change -80.54% 223.81% -44.67%
INVESTING ACTIVITIES
Capital Expenditures $38.30M $42.18M -$35.24M
YoY Change -193.41% -219.7% -234.32%
Acquisitions
YoY Change
Other Investing Activities -$106.2M -$3.000K $2.120M
YoY Change -15.96% -100.14% -102.88%
Cash From Investing Activities -$144.4M -$42.19M -$33.12M
YoY Change -13.73% 27.37% -66.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -259.7M -24.10M 172.2M
YoY Change 59.8% -113.99% -54.11%
NET CHANGE
Cash From Operating Activities 77.20M 499.0M 154.1M
Cash From Investing Activities -144.4M -42.19M -33.12M
Cash From Financing Activities -259.7M -24.10M 172.2M
Net Change In Cash -326.9M 432.7M 293.2M
YoY Change -588.9% 47.59% -47.07%
FREE CASH FLOW
Cash From Operating Activities $77.20M $499.0M $154.1M
Capital Expenditures $38.30M $42.18M -$35.24M
Free Cash Flow $38.90M $456.8M $189.3M
YoY Change -91.11% 141.26% -24.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
234.49
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-86080000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
638323000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166877000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158200000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
262171000 usd
us-gaap Net Income Loss
NetIncomeLoss
454537000 usd
us-gaap Net Income Loss
NetIncomeLoss
480123000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.24
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.10
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73887000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76769000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73705000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77250000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75001000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78239000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74763000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78762000 shares
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
59549000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-158896000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
140656000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
24053000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
17204000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
8500000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
11731000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
26730000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
76753000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-150396000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
152387000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
50783000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
316455000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
111775000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
606924000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
530906000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2541493000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
214835000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
75634000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9597000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26096000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33399000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2881860000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
239702000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
76753000 usd
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2376000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34748000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32749000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3263436000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2866580000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
217952000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
201179000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
422736000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32631000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8810000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2904416000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
262171000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-150396000 usd
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
372566000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34017000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10027000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2687669000 usd
us-gaap Net Income Loss
NetIncomeLoss
454537000 usd
us-gaap Net Income Loss
NetIncomeLoss
480123000 usd
us-gaap Depreciation
Depreciation
53739000 usd
us-gaap Depreciation
Depreciation
43783000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
60844000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
66648000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74418000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52704000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3574000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4131000 usd
flt Amortization Of Intangible Assets And Investment Income Amortization Of Premium
AmortizationOfIntangibleAssetsAndInvestmentIncomeAmortizationOfPremium
114169000 usd
flt Amortization Of Intangible Assets And Investment Income Amortization Of Premium
AmortizationOfIntangibleAssetsAndInvestmentIncomeAmortizationOfPremium
111493000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1934000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-11799000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-10864000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
172000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-345000 usd
flt Other Noncash Operating Income Expense
OtherNoncashOperatingIncomeExpense
-1478000 usd
flt Other Noncash Operating Income Expense
OtherNoncashOperatingIncomeExpense
-80000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
365572000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1225705000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-78035000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13088000 usd
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
14611000 usd
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-20576000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-29397000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1283000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
348643000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
510976000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
826680000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41853000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
126694000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
33744000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
78922000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66629000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4401000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201215000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-100373000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
66148000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18837000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11973000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
795302000 usd
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-39000000 usd
us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
482000000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
337000 usd
us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
4351000000 usd
us-gaap Proceeds From Short Term Debt Maturing In More Than Three Months
ProceedsFromShortTermDebtMaturingInMoreThanThreeMonths
1550000000 usd
us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
4817000000 usd
us-gaap Repayments Of Short Term Debt Maturing In More Than Three Months
RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths
1356000000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
255750000 usd
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
194000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
264000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-241811000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
122392000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38401000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41866000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
422055000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
105738000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2289180000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2250695000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2711235000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2356433000 usd
us-gaap Interest Paid Net
InterestPaidNet
215850000 usd
us-gaap Interest Paid Net
InterestPaidNet
73323000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
238769000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
215653000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Use of estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. These financial statements were prepared using information reasonably available to us as of June 30, 2023 and through the date of this Quarterly Report. The accounting estimates used in the preparation of the Company’s interim consolidated financial statements may change as new events occur, as more experience is acquired, as additional information is obtained and as the Company’s operating environment changes. Actual results may differ from these estimates due to the uncertainty around the ongoing conflict between Russia and Ukraine, the impact of changes to monetary policy, as well as other factors.</span></div>
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
900000 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1800000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
200000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2200000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3501591000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
172080000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149846000 usd
CY2023Q2 us-gaap Revenues
Revenues
948200000 usd
CY2022Q2 us-gaap Revenues
Revenues
861300000 usd
us-gaap Revenues
Revenues
1849500000 usd
us-gaap Revenues
Revenues
1650500000 usd
CY2023Q2 us-gaap Revenues
Revenues
948200000 usd
CY2022Q2 us-gaap Revenues
Revenues
861300000 usd
us-gaap Revenues
Revenues
1849500000 usd
us-gaap Revenues
Revenues
1650500000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
50800000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57700000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
33600000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17200000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
25800000 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications and Adjustments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain disclosures for prior periods have been reclassified to conform with current year presentation, including the breakout of derivatives assets and liabilities, net within the Consolidated Statements of Cash Flows, and the presentation of disaggregated revenues by solution to align with our revenues by segment presentation.</span></div>
CY2023Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3880730000 usd
CY2023Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
3708650000 usd
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
3351745000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149846000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
98719000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
74418000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
52704000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
65167000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
33416000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
5943000 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
4350000 usd
flt Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
7040000 usd
flt Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
2481000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
172080000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
124838000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1085549000 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
210906000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
761088000 usd
CY2022Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
224725000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
69700000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34748000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34017000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60844000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
66648000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
6300000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
20000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
132802000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5301000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
188.12
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3512000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
159.46
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
113681000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
186000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
203.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
67.47
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
401000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
158.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
22968000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
77000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
242.12
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5009000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
190.27
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3383000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
164.87
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
316912000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
775000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
223.27
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
293700000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
435000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
237.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
438000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
213.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
251000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
239.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
17000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
605000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
219.39
CY2022Q4 us-gaap Goodwill
Goodwill
5201435000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
178865000 usd
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1877000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
91426000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5473603000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3871259000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1764178000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2107081000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
3748353000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1617379000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2130974000 usd
us-gaap Finite Lived Intangible Assets Foreign Currency Translation Gain Loss
FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss
29600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
113300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109900000 usd
CY2023Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2340000 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
2950000 usd
CY2023Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
5501489000 usd
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
5749894000 usd
CY2023Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
1248000000 usd
CY2022Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
1287000000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6749489000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7036894000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2071231000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2314056000 usd
CY2023Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4678258000 usd
CY2022Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
4722838000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6749489000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
7036894000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
239702000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
262171000 usd
us-gaap Net Income Loss
NetIncomeLoss
454537000 usd
us-gaap Net Income Loss
NetIncomeLoss
480123000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73887000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76769000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73705000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
77250000 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1114000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1470000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1058000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1512000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75001000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78239000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
74763000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78762000 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.24
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.22
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.20
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.10
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 segment
CY2023Q2 us-gaap Revenues
Revenues
948174000 usd
CY2022Q2 us-gaap Revenues
Revenues
861278000 usd
us-gaap Revenues
Revenues
1849507000 usd
us-gaap Revenues
Revenues
1650519000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
412650000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
370480000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
787845000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
688201000 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
83676000 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78474000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
167908000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155276000 usd
CY2023Q2 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
51444400000 usd
CY2022Q4 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
40496400000 usd
CY2019Q1 flt Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
3 derivative_instrument
CY2023Q1 flt Derivative Number Of Cash Flow Hedges Entered Into
DerivativeNumberOfCashFlowHedgesEnteredInto
5 derivative_instrument
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
28200000 usd
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
167196000 usd
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
12392000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2417000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
152387000 usd
us-gaap Oci Before Reclassifications Before Tax Attributable To Parent
OciBeforeReclassificationsBeforeTaxAttributableToParent
46924000 usd
us-gaap Reclassification From Aoci Current Period Before Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent
-12674000 usd
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
8815000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
50783000 usd
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-23-028574-index-headers.html Edgar Link pending
0001628280-23-028574-index.html Edgar Link pending
0001628280-23-028574.txt Edgar Link pending
0001628280-23-028574-xbrl.zip Edgar Link pending
ex311q22023.htm Edgar Link pending
ex312q22023.htm Edgar Link pending
ex321q22023.htm Edgar Link pending
ex322q22023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
flt-20230630.htm Edgar Link pending
flt-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
flt-20230630_cal.xml Edgar Link unprocessable
flt-20230630_def.xml Edgar Link unprocessable
flt-20230630_lab.xml Edgar Link unprocessable
flt-20230630_pre.xml Edgar Link unprocessable
flt-20230630_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable